Comparison of chemoradiotherapy with radiotherapy alone for "biopsy only" anaplastic astrocytoma.

about

Comparison of chemoradiotherapy with radiotherapy alone for "biopsy only" anaplastic astrocytoma.

Item

http://www.wikidata.org/entity/Q42366659

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Comparison of chemoradiotherap ...... only" anaplastic astrocytoma.

@en

Comparison of chemoradiotherap ...... only" anaplastic astrocytoma.

@nl

type

Item

label

Comparison of chemoradiotherap ...... only" anaplastic astrocytoma.

@en

Comparison of chemoradiotherap ...... only" anaplastic astrocytoma.

@nl

prefLabel

Comparison of chemoradiotherap ...... only" anaplastic astrocytoma.

@en

Comparison of chemoradiotherap ...... only" anaplastic astrocytoma.

@nl

P1476

Comparison of chemoradiotherap ...... only" anaplastic astrocytoma.

@en

P2093

Bo Xiao

http://www.w3.org/2001/XMLSchema#string

Giorgos Karakousis

http://www.w3.org/2001/XMLSchema#string

Harrison Xiao Bai

http://www.w3.org/2001/XMLSchema#string

Jing Wu

http://www.w3.org/2001/XMLSchema#string

Li Yang

http://www.w3.org/2001/XMLSchema#string

MacLean Nasrallah

http://www.w3.org/2001/XMLSchema#string

Paul J Zhang

http://www.w3.org/2001/XMLSchema#string

Ting Zou

http://www.w3.org/2001/XMLSchema#string

Xuejun Li

http://www.w3.org/2001/XMLSchema#string

Ya Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Prognostic factors for anaplastic astrocytomas.

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma.

Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma.

Anaplastic astrocytoma in adults.

P304

69038-69046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17441

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28978179

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5620319

http://www.w3.org/2001/XMLSchema#string